OraSure Technologies Return on Investment 2010-2024 | OSUR
Current and historical return on investment (ROI) values for OraSure Technologies (OSUR) over the last 10 years.
| OraSure Technologies ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-12-31 |
$-0.03B |
$0.41B |
-6.64% |
| 2024-09-30 |
$-0.01B |
$0.43B |
-2.81% |
| 2024-06-30 |
$0.01B |
$0.43B |
1.18% |
| 2024-03-31 |
$0.00B |
$0.43B |
0.48% |
| 2023-12-31 |
$0.03B |
$0.43B |
8.12% |
| 2023-09-30 |
$0.04B |
$0.41B |
11.28% |
| 2023-06-30 |
$0.03B |
$0.40B |
9.08% |
| 2023-03-31 |
$0.02B |
$0.40B |
5.24% |
| 2022-12-31 |
$-0.02B |
$0.37B |
-5.92% |
| 2022-09-30 |
$-0.05B |
$0.34B |
-12.53% |
| 2022-06-30 |
$-0.06B |
$0.35B |
-15.89% |
| 2022-03-31 |
$-0.04B |
$0.37B |
-9.32% |
| 2021-12-31 |
$-0.01B |
$0.38B |
-2.53% |
| 2021-09-30 |
$0.01B |
$0.39B |
1.75% |
| 2021-06-30 |
$0.02B |
$0.41B |
6.01% |
| 2021-03-31 |
$0.01B |
$0.40B |
3.30% |
| 2020-12-31 |
$-0.01B |
$0.40B |
-1.37% |
| 2020-09-30 |
$-0.01B |
$0.39B |
-2.62% |
| 2020-06-30 |
$0.00B |
$0.38B |
0.00% |
| 2020-03-31 |
$0.01B |
$0.29B |
4.70% |
| 2019-12-31 |
$0.02B |
$0.31B |
6.10% |
| 2019-09-30 |
$0.03B |
$0.30B |
12.39% |
| 2019-06-30 |
$0.03B |
$0.29B |
17.54% |
| 2019-03-31 |
$0.03B |
$0.28B |
37.01% |
| 2018-12-31 |
$0.03B |
|
0.00% |
| 2018-09-30 |
$0.03B |
|
0.00% |
| 2018-06-30 |
$0.02B |
|
0.00% |
| 2018-03-31 |
$0.02B |
|
0.00% |
| 2017-12-31 |
$0.04B |
|
0.00% |
| 2017-09-30 |
$0.04B |
|
0.00% |
| 2017-06-30 |
$0.04B |
|
0.00% |
| 2017-03-31 |
$0.03B |
|
0.00% |
| 2016-12-31 |
$0.02B |
|
0.00% |
| 2016-09-30 |
$0.02B |
|
0.00% |
| 2016-06-30 |
$0.01B |
|
0.00% |
| 2016-03-31 |
$0.01B |
|
0.00% |
| 2015-12-31 |
$0.01B |
|
0.00% |
| 2015-09-30 |
$0.00B |
|
0.00% |
| 2015-06-30 |
$0.00B |
|
0.00% |
| 2015-03-31 |
$0.00B |
|
0.00% |
| 2014-12-31 |
$-0.01B |
|
0.00% |
| 2014-09-30 |
$0.00B |
|
0.00% |
| 2014-06-30 |
$0.00B |
|
0.00% |
| 2014-03-31 |
$-0.01B |
|
0.00% |
| 2013-12-31 |
$-0.01B |
|
0.00% |
| 2013-09-30 |
$-0.03B |
|
0.00% |
| 2013-06-30 |
$-0.03B |
|
0.00% |
| 2013-03-31 |
$-0.02B |
|
0.00% |
| 2012-12-31 |
$-0.02B |
|
0.00% |
| 2012-09-30 |
$-0.01B |
|
0.00% |
| 2012-06-30 |
$-0.01B |
|
0.00% |
| 2012-03-31 |
$-0.01B |
|
0.00% |
| 2011-12-31 |
$-0.01B |
|
0.00% |
| 2011-09-30 |
$-0.01B |
|
0.00% |
| 2011-06-30 |
$-0.01B |
|
0.00% |
| 2011-03-31 |
$-0.01B |
|
0.00% |
| 2010-12-31 |
$0.00B |
|
-14.55% |
| 2010-09-30 |
$-0.01B |
|
-10.81% |
| 2010-06-30 |
$0.00B |
|
-4.76% |
| 2010-03-31 |
$-0.01B |
$0.11B |
-7.16% |
| 2009-12-31 |
$-0.01B |
$0.11B |
-7.08% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.228B |
$0.186B |
|
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
|
